We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.85 | 2.80 | 2.90 | 2.85 | 2.85 | 2.85 | 515,871 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.17 | 135.84M |
From Apr 2019 to Apr 2024
TIDMAGY
RNS Number : 1689G
Allergy Therapeutics PLC
18 November 2015
18 November 2015
Allergy Therapeutics plc
("Allergy Therapeutics" or the 'Company")
Result of Annual General Meeting
Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that at the Annual General Meeting held today, all the resolutions put to that meeting were duly passed.
For further information:
Allergy Therapeutics +44 (0) 1903 845 820 Manuel Llobet, Chief Executive Officer Ian Postlethwaite, Finance Director Panmure Gordon +44 (0) 20 7886 2500 Freddy Crossley / Peter Steel / Duncan Monteith, Corporate Finance Tom Salvesen, Corporate Broking FTI Consulting +44 (0) 20 3727 1000 Simon Conway / Mo Noonan / Victoria Foster Mitchell
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of GBP43 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGFFEFEAFISEEF
(END) Dow Jones Newswires
November 18, 2015 07:23 ET (12:23 GMT)
1 Year Allergy Therapeutics Chart |
1 Month Allergy Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
